Selective IgA deficiency is defined as absolute or partial when serum IgA level is < 7 mg/dl or 2 SD below normal for age, respectively. Few data are available on partial selective IgA deficiency, as probably most children with low serum IgA are seldom referred to a specialist clinic in common pediatric practice. The aim of our study was to better define the profile of both symptomatic forms and their clinical outcome in a pediatric immunology setting. Thus, clinical and immunological data from 103 symptomatic patients with selective IgA deficiency (53 absolute and 50 partial), 4-18 years of age, were collected at diagnosis and 80 patients (44 absolute and 36 partial) were monitored for a mean period of 5 years. Also, the prevalence of TNFRSF13B mutations has been assessed in 56 patients. The most common clinical features were infections (86/103; 83%), allergy (39/103; 38%), and autoimmunity (13/103; 13%). No significative differences were observed between absolute and partial selective IgA deficiency patients. However, a significative difference in the rate of IgA normalization between partial and absolute selective IgA deficiency patients (33 vs 9%, p = 0.01) was detected. Furthermore, a lower incidence of infections was associated to a normalization reversal compared to a final absolute or partial defect status (12 vs 53 and 64% respectively, p < 0.01).

Follow-up and outcome of symptomatic partial or absolute IgA deficiency in children / Moschese, V; Chini, L; Graziani, S; Sgrulletti, M; Gallo, V; Di Matteo, G; Ferrari, S; Di Cesare, S; Cirillo, E; Pession, A; Pignata, C; Specchia, F.. - In: EUROPEAN JOURNAL OF PEDIATRICS. - ISSN 0340-6199. - 11:(2019), pp. 51-60. [10.1007/s00431-018-3248-1]

Follow-up and outcome of symptomatic partial or absolute IgA deficiency in children

Moschese V;Cirillo E;Pignata C;
2019

Abstract

Selective IgA deficiency is defined as absolute or partial when serum IgA level is < 7 mg/dl or 2 SD below normal for age, respectively. Few data are available on partial selective IgA deficiency, as probably most children with low serum IgA are seldom referred to a specialist clinic in common pediatric practice. The aim of our study was to better define the profile of both symptomatic forms and their clinical outcome in a pediatric immunology setting. Thus, clinical and immunological data from 103 symptomatic patients with selective IgA deficiency (53 absolute and 50 partial), 4-18 years of age, were collected at diagnosis and 80 patients (44 absolute and 36 partial) were monitored for a mean period of 5 years. Also, the prevalence of TNFRSF13B mutations has been assessed in 56 patients. The most common clinical features were infections (86/103; 83%), allergy (39/103; 38%), and autoimmunity (13/103; 13%). No significative differences were observed between absolute and partial selective IgA deficiency patients. However, a significative difference in the rate of IgA normalization between partial and absolute selective IgA deficiency patients (33 vs 9%, p = 0.01) was detected. Furthermore, a lower incidence of infections was associated to a normalization reversal compared to a final absolute or partial defect status (12 vs 53 and 64% respectively, p < 0.01).
2019
Follow-up and outcome of symptomatic partial or absolute IgA deficiency in children / Moschese, V; Chini, L; Graziani, S; Sgrulletti, M; Gallo, V; Di Matteo, G; Ferrari, S; Di Cesare, S; Cirillo, E; Pession, A; Pignata, C; Specchia, F.. - In: EUROPEAN JOURNAL OF PEDIATRICS. - ISSN 0340-6199. - 11:(2019), pp. 51-60. [10.1007/s00431-018-3248-1]
File in questo prodotto:
File Dimensione Formato  
Moschese2018_Article_Follow-upAndOutcomeOfSymptomat.pdf

accesso aperto

Tipologia: Documento in Post-print
Licenza: Dominio pubblico
Dimensione 641.76 kB
Formato Adobe PDF
641.76 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/723840
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 19
  • ???jsp.display-item.citation.isi??? 17
social impact